CRBPNasdaqPharmaceutical Preparations

Corbus Pharmaceuticals Holdings, Inc. (CRBP) earnings date, market-implied expected move, and options open interest by expiry

3.06

+0.20 · +7.15%

post 3.06 −0.14%

Closed16:05 ET

Open2.98Volume1.4MMkt cap$55.3M

Day2.96 – 3.1071%52-wk2.81 – 12.882%

CRBP

Corbus Pharmaceuticals Holdings, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 11

before open · in 5 days

est.Q3 FY26

Calendar

Next report

Last report

+1.78%

vs ±15.6% implied · ×0.11

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+27.17%

shares held · 10 largest managers

13F · Jun 30 '26130d lag

107 managers

Top fund weight

0.00%

CRBP weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Corbus Pharmaceuticals (CRBP) is expected to report on Nov 11 before open (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 6 '26confirmed±15.6%▲+1.78%×0.11

quarterimplied−20%0+20%realized×

Q2 FY26±15.6%▲+1.78%×0.11

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Nov 5 close

0.01OI · 3 expiries · Nov 5 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

40%Nov 2014d308+1%

19,3850%Dec 1842d0.7326,6890%0.73

3450%Mar 19133d0.084,398+4%0.08

ExpiryPutsCallsP/C

Nov 2014d40%308+1%0.01

Dec 1842d19,3850%26,6890%0.73

Mar 19133d3450%4,398+4%0.08

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−3010.05%as filednet margin · revenue −16.98% QoQ · −11.42% YoY

Revenue$1M−16.98%

Gross profit$1M100.00%−16.98%

Operating income−$36M−3109.11%−48.91%

Pre-tax income−$35M+23.91%

Net income−$35M−3010.05%+23.73%

Cost of revenue$0—

Operating expenses$36M−25.55%

Other expense−$11,000−100.95%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×0.87· ±3.8% vs ±4.3% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±3.8%9 of 24×0.87

PPIproducer prices±3.8%5 of 10×0.87

CPROFcorporate profits±3.4%6 of 12×0.80

NFPjobs report±3.3%3 of 10×0.76

GDPgross domestic product±2.7%9 of 19×0.64

PCEpersonal income & outlays±2.6%8 of 19×0.60

CPIconsumer prices±2.1%3 of 10×0.50

Bar = avg |move| to ±5% · tick = ±4.3% avg day · ×base = |move| ÷ ±4.3% · min 6 releases

Earnings history

EPS -1.81 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-1.81	—
Q1 FY26	—	-1.23	—
Q3 FY25	—	-1.90	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod